Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
First half pre-tax losses at Transdermal Cosmetics fell to 275,000 from 404,000 last time.
The operating loss for the six months to the end of August narrowed to 285,000 from 336,000 a year ago.
TDC focuses on the production, distribution and commercialisation of cosmetics produced using a proprietary technology, called Soma ZoneTM.
This facilitates the delivery of a variety of cosmetic substances such as collagen and elastin, which have high density molecular weights, into the skin without the use of needles or causing skin inflammation.
The first product to be launched, Entre Derm which is an anti-ageing cream, has undergone a clinical trial in the US with the results verified by a leading US doctor.
The company remains pre-revenue, although it expects to record its first sales before the end of February 2010.
Story provided by Business Financial Newswire
Shares in British banks rose on the FTSE 100 in morning trading following positive news on the Greek debt crisis.
Unite, the union, has gone to international unions, in its attempts to bring the...
© 2010 The IBTimes Company Ltd. All Rights Reserved.
Partners 
EMAIL
PRINT
RSS
SHARE
